Oseltamivir boosts 2009 H1N1 virus infectivity in vitro

Biochemical and Biophysical Research Communications

Volumn 390, Issue 4, 2009, Pages 1305-1308

  Lin, Xiaojing ^a   Zhou, Jianfang ^a   Zhang, Yonghui ^a   Wu, Jia ^a   Zhang, Fengwei ^a   Li, Zi ^a   Zhang, Ye ^a   Bi, Shengli ^a   Shu, Yuelong ^a   Wang, Yue ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Influenza A virus (H1N1); Oseltamivir

Indexed keywords

OSELTAMIVIR;

ARTICLE; CLINICAL PRACTICE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; EMBRYO; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; INFLUENZA VIRUS A H1N1; PRIORITY JOURNAL; VIRUS INFECTIVITY;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; ENZYME INHIBITORS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MICE; NEURAMINIDASE; OSELTAMIVIR; VIRUS INTERNALIZATION;

INFLUENZA A VIRUS;

EID: 70450250079     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.10.142     Document Type: Article

References (15)

1. Knipe D.M., and Howley P.M. Field Virology. fifth ed. (2007), Lippincott Williams & Wilkins Immunology
2. Couceiro J.N., Paulson J.C., and Baum L.G. Influenza virus strains selectively recognize sialyloligosaccharides on human respiratory epithelium; the role of the host cell in selection of hemagglutinin receptor specificity. Virus Res. 29 (1993) 155-165
3. Rogers G.N., Pritchett T.J., Lane J.L., et al. Differential sensitivity of human, avian, and equine influenza A viruses to a glycoprotein inhibitor of infection: selection of receptor specific variants. Virology 131 (1983) 394-408
4. Childs R.A., Palma A.S., Wharton S., et al. Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray. Nat. Biotechnol. 27 (2009) 797-799
5. Palese P., Tobita K., Ueda M., et al. Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology 61 (1974) 397-410
6. Kobasa D., Wells K., and Kawaoka Y. Amino acids responsible for the absolute sialidase activity of the influenza A virus neuraminidase: relationship to growth in the duck intestine. J. Virol. 75 (2001) 11773-11780
7. Tamiflu Approval, Review, and Labeling Information. Drugs@FDA. US FDA. (accessed 15.09.09).
8. Hayden F.G., Treanor J.J., Fritz R.S., et al. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA 282 (1999) 1240-1246
9. World Health Organization EML - Oseltamivir phosphate. (accessed 15.09.09).
10. Zhang Y., Lin X., Zhang F., et al. Hemagglutinin and neuraminidase matching patterns of two influenza A virus strains related to the 1918 and 2009 global pandemics. Biochem. Biophys. Res. Commun. 387 (2009) 405-408
11. Shinya K., Ebina M., Yamada S., et al. Avian flu: influenza virus receptors in the human airway. Nature 440 (2006) 435-436
12. Glaser L., Stevens J., Zamarin D., et al. A single amino acid substitution in 1918 influenza virus hemagglutinin changes receptor binding specificity. J. Virol. 79 (2005) 11533-11536
13. de Jong M.D., Tran T.T., Truong H.K., et al. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N. Engl. J. Med. 353 (2005) 2667-2672
14. Centers for Disease Control and Prevention (CDC). MMWR Morb. Mortal. Wkly. Rep. 58 (2009) 941-947
15. Centers for Disease Control and Prevention (CDC). MMWR Morb. Mortal. Wkly. Rep. 58 (2009) 969-972